-transparent.png){kind=logo}
The products of the 5- and 12-lipoxygenase (5-LO, 12-LO) pathways of arachidonic acid metabolism are implicated as proinflammatory mediators in a number of disease states. 12(R)-hydroxyeicosatetraenoic acid [12(R)-HETE] is present in large quantities in human psoriatic lesional skin and can be further metabolized by 5-LO to 5(S), 12(R)-dihydroxy-(6E,8Z,10E,14Z)-eicosatetraenoic acid (6-trans-LTB4). Furthermore, leukotriene B4 (LTB4) and the sulfidopeptide leukotrienes (LTC4, LTD4) can be transformed to 6-trans-LTB4. When injected into the guinea pig dermis, 6-trans-LTB4 (1.0, 10.0, 20.0 micrograms/intradermal site) caused a significant (P less than 0.02) infiltration of polymorphonuclear leukocytes (PMN) at 4 hr as assessed by histology and the levels of the PMN marker enzyme myeloperoxidase. 6-trans-LTB4 is a more potent PMN chemoattractant than 12(R)-HETE in the guinea pig dermis but is far less potent than LTB4. Pharmacological interdiction of leukotriene production or receptor binding should take into account the proinflammatory activity of 6-trans-LTB4.
D J Fretland, and
D L Widomski, and
C P Anglin, and
R E Walsh, and
S Levin, and
T S Gaginella
April 1993,
Prostaglandins,
D J Fretland, and
D L Widomski, and
C P Anglin, and
R E Walsh, and
S Levin, and
T S Gaginella
September 1991,
The Journal of pharmacology and experimental therapeutics,
D J Fretland, and
D L Widomski, and
C P Anglin, and
R E Walsh, and
S Levin, and
T S Gaginella
February 1987,
Biochemical and biophysical research communications,
D J Fretland, and
D L Widomski, and
C P Anglin, and
R E Walsh, and
S Levin, and
T S Gaginella
May 1987,
Journal of neurochemistry,
D J Fretland, and
D L Widomski, and
C P Anglin, and
R E Walsh, and
S Levin, and
T S Gaginella
November 1990,
Prostaglandins,
D J Fretland, and
D L Widomski, and
C P Anglin, and
R E Walsh, and
S Levin, and
T S Gaginella
February 1983,
Prostaglandins,
D J Fretland, and
D L Widomski, and
C P Anglin, and
R E Walsh, and
S Levin, and
T S Gaginella
November 1991,
Journal of immunology (Baltimore, Md. : 1950),
D J Fretland, and
D L Widomski, and
C P Anglin, and
R E Walsh, and
S Levin, and
T S Gaginella
March 1983,
Prostaglandins,
D J Fretland, and
D L Widomski, and
C P Anglin, and
R E Walsh, and
S Levin, and
T S Gaginella
June 1986,
The Journal of pharmacology and experimental therapeutics,
D J Fretland, and
D L Widomski, and
C P Anglin, and
R E Walsh, and
S Levin, and
T S Gaginella
March 1990,
Journal of immunology (Baltimore, Md. : 1950),
